{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:04:27Z","timestamp":1789070667117,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtct.2025.06.031","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T21:31:50Z","timestamp":1751664710000},"page":"1138.e1-1138.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and Risk Factors of Skin Cancer and Preneoplastic Lesions after Autologous and Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6730-6723","authenticated-orcid":false,"given":"Miguel","family":"Mansilla-Polo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Montoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"L\u00f3pez-Davia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana","family":"Balaguer-Rosello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Villalba-Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-971X","authenticated-orcid":false,"given":"Pedro","family":"Chor\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6504-3656","authenticated-orcid":false,"given":"Pedro","family":"Asensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier De","family":"la Rubia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"de Unamuno-Bustos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7918-4733","authenticated-orcid":false,"given":"Daniel","family":"Mart\u00edn-Torregrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Abril-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicent","family":"Mart\u00ednez-C\u00f3zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Llavador-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Botella-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6934-4619","authenticated-orcid":false,"given":"Jaime","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.06.031_bib0001","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","article-title":"New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors","volume":"21","author":"Baker","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0002","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.06.031_bib0003","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamadermatol.2015.3902","article-title":"Skin Cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0004","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","article-title":"Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning","volume":"20","author":"Ringd\u00e9n","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbmt.2012.09.023","article-title":"Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma","volume":"19","author":"Krishnan","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0006","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/bmt.2014.13","article-title":"Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study","volume":"49","author":"Bilmon","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0007","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamadermatol.2015.121","article-title":"Cutaneous malignant neoplasms in hematopoietic cell transplant recipients: a systematic review","volume":"151","author":"DePry","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0008","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation","volume":"24","author":"Leisenring","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0009","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3324\/haematol.2022.281256","article-title":"Post-transplant cyclophosphamide: overcoming the HLA barrier to hematopoietic stem cell transplants","volume":"107","author":"Bacigalupo","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2025.06.031_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12877-022-02964-1","article-title":"Skin cancers and their risk factors in older persons: a population-based study","volume":"22","author":"Sinikumpu","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jtct.2025.06.031_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0303-6987.2006.00516.x","article-title":"Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification\u2013part two","volume":"33","author":"Cassarino","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41409-024-02319-x","article-title":"Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience","author":"Sanz","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0013","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41409-020-0921-6","article-title":"Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors","volume":"55","author":"Montoro","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0014","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/07853890.2014.952662","article-title":"Autologous hematopoietic cell transplantation: an update for clinicians","volume":"46","author":"Hamadani","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/j.jtct.2025.06.031_bib0015","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0016","series-title":"International classification of diseases for oncology (ICD-O)","year":"2013"},{"key":"10.1016\/j.jtct.2025.06.031_bib0017","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.6004\/jnccn.2023.0056","article-title":"Basal cell skin cancer, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schmults","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2025.06.031_bib0018","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.6004\/jnccn.2021.0059","article-title":"NCCN Guidelines\u00ae insights: squamous cell skin cancer, version 1.2022: featured updates to the NCCN guidelines","volume":"19","author":"Schmults","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2025.06.031_bib0019","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2024.5016","article-title":"Basal cell and squamous cell skin cancers: NCCN guidelines updates based on risk status","volume":"22","author":"Bordeaux","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2025.06.031_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00432-024-05679-5","article-title":"Secondary solid malignancies and precancerous lesions after allogeneic hematopoietic stem cell transplantation using non-total body irradiation-based conditioning in acute myeloid leukemia","volume":"150","author":"Isabella","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0021","doi-asserted-by":"crossref","first-page":"888","DOI":"10.36849\/JDD.6078","article-title":"Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report","volume":"20","author":"Rosso","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0022","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MPH.0b013e31828e5d96","article-title":"Nonmelanoma skin cancer in childhood after hematopoietic stem cell transplant: a report of 4 cases","volume":"36","author":"Rork","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0023","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.3442.3442","article-title":"Voriconazole and non-melanoma skin cancer after allogeneic HSCT: results of a prospective dedicated follow-up program in 302 patients","volume":"128","author":"Lupo-Stanghellini","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.06.031_bib0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jamadermatol.2020.0559","article-title":"Risk factors for keratinocyte carcinoma in recipients of allogeneic hematopoietic cell transplants","volume":"156","author":"Scott","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/bmt.2017.57","article-title":"Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantation","volume":"52","author":"Song","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0026","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jid.2018.08.025","article-title":"Reduced-intensity conditioning regimens, prior chronic lymphocytic leukemia, and graft-versus-host disease are associated with higher rates of skin cancer after allogeneic hematopoietic stem cell transplantation","volume":"139","author":"Wu","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0027","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaad.2019.10.034","article-title":"Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation","volume":"83","author":"Herr","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0028","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41409-023-02138-6","article-title":"Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland","volume":"59","author":"Wong","year":"2024","journal-title":"Aus Bone Marrow Transpl"},{"key":"10.1016\/j.jtct.2025.06.031_bib0029","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.06.031_bib0030","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2017.06.032","article-title":"Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation","volume":"77","author":"Kuklinski","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0031","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2011.23","article-title":"Secondary solid tumors after allogeneic hematopoietic SCT in Japan","volume":"47","author":"Yokota","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0032","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/bloodadvances.2019000839","article-title":"Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases","volume":"4","author":"Kahn","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.06.031_bib0033","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.bbmt.2014.12.028","article-title":"New cancers after autotransplantations for multiple myeloma","volume":"21","author":"Mahindra","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.06.031_bib0034","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.06.031_bib0035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","article-title":"Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning","volume":"117","author":"Majhail","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.06.031_bib0036","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/cncr.21971","article-title":"The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma","volume":"107","author":"Tward","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2025.06.031_bib0037","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/tid.12367","article-title":"Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients","volume":"17","author":"Wojenski","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jtct.2025.06.031_bib0038","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1667\/RR1469.1","article-title":"Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation","volume":"171","author":"Schwartz","year":"2009","journal-title":"Radiat Res"},{"key":"10.1016\/j.jtct.2025.06.031_bib0039","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0040","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v101.544","article-title":"Risk factors and rate of recurrence after Mohs surgery in basal cell and squamous cell carcinomas: a nationwide prospective cohort (REGESMOHS, Spanish registry of Mohs surgery)","volume":"101","author":"Tom\u00e1s-Vel\u00e1zquez","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jtct.2025.06.031_bib0041","doi-asserted-by":"crossref","first-page":"29","DOI":"10.12788\/cutis.0914","article-title":"Squamous cell carcinoma arising in chronic inflammatory dermatoses","volume":"113","author":"Kuraitis","year":"2024","journal-title":"Cutis"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T19:58:29Z","timestamp":1788551909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725012850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666636725012850"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.031","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Risk Factors of Skin Cancer and Preneoplastic Lesions after Autologous and Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.06.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}